SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, announced that it was notified by the Nasdaq Office of General Counsel that the Company regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2) as a result of the […]
Category Archives: Pr Newswire
Pr Newswire
Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation
19
Jul
Jul
MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the European Union Medical Device Regulation (EU MDR) has approved additional magnetic resonance imaging (MRI) scan […]
Pr Newswire
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
19
Jul
Jul
MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced CE mark certification under the European Union’s Medical Device Regulation (EU MDR 2017/745) for Inspire therapy. “Inspire […]
19
Jul
Jul
Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus Preparedness NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised a procurement option for the delivery of approximately $113 million of oral TPOXX® […]
Free business platform for local SMEs and Sands retailers July 18-21 Supports Macao government’s “tourism+” initiative MACAO, July 19, 2024 /PRNewswire/ — Sands China’s annual signature event, the 2024 Sands Shopping Carnival, kicked off Thursday at The Venetian® Macao with an opening ceremony attended by representatives from the government, finance, business, and community services sectors. […]
KIIT-KISS Founder announces Rs 7 lakh to each of the athletes BHUBANESWAR, India, July 19, 2024 /PRNewswire/ — In a big achievement for KIIT Deemed to be University (KIIT-DU), Bhubaneswar, 12 students have successfully qualified for the Paris Olympics 2024 beginning July 26, bringing pride and joy to the institution. KIIT-KISS Dr Achyuta Samanta (third from […]
NEW YORK, July 19, 2024 /PRNewswire/ — Krane Funds Advisors, LLC (“KraneShares”), an asset management firm known for its global exchange-traded funds (ETFs), launched the KraneShares Artificial Intelligence & Technology ETF (Ticker: AGIX) on the Nasdaq Stock Market (NASDAQ) on July 18th, 2024. AGIX tracks the Solactive Etna Artificial General Intelligence Index, which is designed […]
TOKYO, July 19, 2024 /PRNewswire/ — Baseus, a leading global brand of consumer electronics and mobile phone accessories, has achieved remarkable success on Amazon Japan, becoming one of the brand’s primary sales channels in the country. Baseus posted its strongest sales on the site in the first half of 2024 thanks to the high popularity […]
TAIAN, China, July 19, 2024 /PRNewswire/ — This is a report from the Shandong Office of Hong Kong Business Daily. Recently, the opening ceremony of Mount Taishan Tianping Lake Tourist Center and the departure ceremony of the “dare to” Mount Taishan through train were held in Tai’an, Shandong Province. “When I first arrived at the tourist […]
Pr Newswire
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
19
Jul
Jul
SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the pricing of its upsized initial public offering of 13,920,000 shares of common stock at a price […]